NIH-funded research Sbir 2 grant

A new system for monitoring hexavalent chromium in water

Official title: Automated, in-line hexavalent chromium analyzer

Funded at Ondavia, INC. · NIH-10922498 · Data updated 2026-11-12

This study is testing a new system that can automatically check for harmful levels of hexavalent chromium in drinking and ground water, making it easier to keep our water safe and healthy for everyone.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionOndavia, INC.
NIH-funded
Lab location1 site (Hayward, United States)
Project startSeptember 3, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$586,190
NIH project number1R44ES035679-01A1
Project IDNIH-10922498 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in areas where water sources may be contaminated with hexavalent chromium or other hazardous metals.

Less likely to help

Patients who do not reside in regions with potential chromium contamination or who are not concerned about water quality may not benefit from this research.

What this research studies

This research focuses on developing a prototype system that can autonomously monitor hexavalent chromium levels in drinking and ground water. The OndaVia system uses consumable cassettes and advanced optical methods to analyze water samples without the need for calibration, providing quick and accurate results. The technology aims to improve water safety by enabling continuous monitoring of contaminants, which is crucial for public health. If successful, this system could be used in various settings, including municipal water supplies and industrial applications.

Why it matters

Potential benefit: This research could lead to safer drinking water by providing a reliable method for detecting harmful levels of hexavalent chromium.

How similar studies have gone: Other research has successfully developed similar in-line monitoring technologies for water contaminants, indicating a promising avenue for this approach.

Where this research is happening

  • Ondavia, INC.
    Hayward, United States
    Active

Researchers

  • Principal investigator: Peterman, Mark C — Ondavia, INC.
  • Study coordinator: Peterman, Mark C

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.